Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40).

Subbannayya T, Leal-Rojas P, Zhavoronkov A, Ozerov IV, Korzinkin M, Babu N, Radhakrishnan A, Chavan S, Raja R, Pinto SM, Patil AH, Barbhuiya MA, Kumar P, Guerrero-Preston R, Navani S, Tiwari PK, Kumar RV, Prasad TSK, Roa JC, Pandey A, Sidransky D, Gowda H, Izumchenko E, Chatterjee A.

J Cell Commun Signal. 2019 Jun;13(2):163-177. doi: 10.1007/s12079-018-00503-5. Epub 2019 Jan 21.

2.

A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.

Gremel G, Djureinovic D, Niinivirta M, Laird A, Ljungqvist O, Johannesson H, Bergman J, Edqvist PH, Navani S, Khan N, Patil T, Sivertsson Å, Uhlén M, Harrison DJ, Ullenhag GJ, Stewart GD, Pontén F.

BMC Cancer. 2017 Jan 4;17(1):9. doi: 10.1186/s12885-016-3030-6.

3.

A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression.

Eriksson O, Asplund A, Hegde G, Edqvist PH, Navani S, Pontén F, Siegbahn A.

Thromb Haemost. 2016 Nov 30;116(6):1050-1059. Epub 2016 Sep 22.

PMID:
27656710
4.

Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer.

Eriksson O, Thulin Å, Asplund A, Hegde G, Navani S, Siegbahn A.

BMC Cancer. 2016 May 31;16:341. doi: 10.1186/s12885-016-2375-1.

5.
6.

Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.

Subbannayya T, Leal-Rojas P, Barbhuiya MA, Raja R, Renuse S, Sathe G, Pinto SM, Syed N, Nanjappa V, Patil AH, Garcia P, Sahasrabuddhe NA, Nair B, Guerrero-Preston R, Navani S, Tiwari PK, Santosh V, Sidransky D, Prasad TS, Gowda H, Roa JC, Pandey A, Chatterjee A.

BMC Cancer. 2015 Nov 4;15:843. doi: 10.1186/s12885-015-1855-z.

7.

A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.

Sridevi HB, Shanthala PR, Raghuveer CV, Prabhu AK, Akbar JK, Shivaprasad GS, Suresh PK, Navani S.

J Cancer Res Ther. 2015 Jul-Sep;11(3):656. doi: 10.4103/0973-1482.139338.

8.

Proteomics. Tissue-based map of the human proteome.

Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pontén F.

Science. 2015 Jan 23;347(6220):1260419. doi: 10.1126/science.1260419.

9.

FGF2 as a potential prognostic biomarker for proneural glioma patients.

Sooman L, Freyhult E, Jaiswal A, Navani S, Edqvist PH, Pontén F, Tchougounova E, Smits A, Elsir T, Gullbo J, Lennartsson J, Bergqvist M, Ekman S.

Acta Oncol. 2015 Mar;54(3):385-94. doi: 10.3109/0284186X.2014.951492. Epub 2014 Sep 29.

PMID:
25263081
10.

Analysis of candidate genes for lineage-specific expression changes in humans and primates.

Lindskog C, Kuhlwilm M, Davierwala A, Fu N, Hegde G, Uhlén M, Navani S, Pääbo S, Pontén F.

J Proteome Res. 2014 Aug 1;13(8):3596-606. doi: 10.1021/pr500045f. Epub 2014 Jul 15.

PMID:
24911366
11.

Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics.

Sahasrabuddhe NA, Barbhuiya MA, Bhunia S, Subbannayya T, Gowda H, Advani J, Shrivastav BR, Navani S, Leal P, Roa JC, Chaerkady R, Gupta S, Chatterjee A, Pandey A, Tiwari PK.

Biochem Biophys Res Commun. 2014 Apr 18;446(4):863-9. doi: 10.1016/j.bbrc.2014.03.017. Epub 2014 Mar 20.

12.

Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India.

Sharma M, Mannan R, Madhukar M, Navani S, Manjari M, Bhasin TS, Gill KS.

J Clin Diagn Res. 2014 Jan;8(1):46-9. doi: 10.7860/JCDR/2014/8173.3988. Epub 2013 Jan 12.

13.

PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.

Sooman L, Ekman S, Tsakonas G, Jaiswal A, Navani S, Edqvist PH, Pontén F, Bergström S, Johansson M, Wu X, Blomquist E, Bergqvist M, Gullbo J, Lennartsson J.

Tumour Biol. 2014 May;35(5):4479-88. doi: 10.1007/s13277-013-1590-5. Epub 2014 Feb 9.

PMID:
24510345
14.

A systematic analysis of commonly used antibodies in cancer diagnostics.

Gremel G, Bergman J, Djureinovic D, Edqvist PH, Maindad V, Bharambe BM, Khan WA, Navani S, Elebro J, Jirström K, Hellberg D, Uhlén M, Micke P, Pontén F.

Histopathology. 2014 Jan;64(2):293-305. doi: 10.1111/his.12255. Epub 2013 Nov 5.

PMID:
24330150
15.

Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.

Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sjöstedt E, Lundberg E, Szigyarto CA, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson A, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen J, Ponten F, Uhlén M.

Mol Cell Proteomics. 2014 Feb;13(2):397-406. doi: 10.1074/mcp.M113.035600. Epub 2013 Dec 5.

16.

Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival.

Sooman L, Lennartsson J, Gullbo J, Bergqvist M, Tsakonas G, Johansson F, Edqvist PH, Pontén F, Jaiswal A, Navani S, Alafuzoff I, Popova S, Blomquist E, Ekman S.

Med Oncol. 2013;30(3):638. doi: 10.1007/s12032-013-0638-0. Epub 2013 Jun 20.

PMID:
23783486
17.

CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.

Cepeda D, Ng HF, Sharifi HR, Mahmoudi S, Cerrato VS, Fredlund E, Magnusson K, Nilsson H, Malyukova A, Rantala J, Klevebring D, Viñals F, Bhaskaran N, Zakaria SM, Rahmanto AS, Grotegut S, Nielsen ML, Szigyarto CA, Sun D, Lerner M, Navani S, Widschwendter M, Uhlén M, Jirström K, Pontén F, Wohlschlegel J, Grandér D, Spruck C, Larsson LG, Sangfelt O.

EMBO Mol Med. 2013 Jul;5(7):1067-86. doi: 10.1002/emmm.201202341. Epub 2013 Jun 14.

18.

Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP).

Fagerberg L, Oksvold P, Skogs M, Algenäs C, Lundberg E, Pontén F, Sivertsson A, Odeberg J, Klevebring D, Kampf C, Asplund A, Sjöstedt E, Al-Khalili Szigyarto C, Edqvist PH, Olsson I, Rydberg U, Hudson P, Ottosson Takanen J, Berling H, Björling L, Tegel H, Rockberg J, Nilsson P, Navani S, Jirström K, Mulder J, Schwenk JM, Zwahlen M, Hober S, Forsberg M, von Feilitzen K, Uhlén M.

J Proteome Res. 2013 Jun 7;12(6):2439-48. doi: 10.1021/pr300924j. Epub 2012 Dec 31.

PMID:
23276153
19.

A tool to facilitate clinical biomarker studies--a tissue dictionary based on the Human Protein Atlas.

Kampf C, Bergman J, Oksvold P, Asplund A, Navani S, Wiking M, Lundberg E, Uhlén M, Ponten F.

BMC Med. 2012 Sep 12;10:103. doi: 10.1186/1741-7015-10-103.

20.

Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.

de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma SR, Vikas M, Navani S, Pontén F, Meijer GA, Fijneman RJ.

Gut. 2012 Jun;61(6):855-64. doi: 10.1136/gutjnl-2011-300511. Epub 2011 Sep 2.

PMID:
21890811
21.

SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.

Magnusson K, de Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CA, Navani S, Uhlén M, O'Connor DP, Jirström K, Pontén F.

Am J Surg Pathol. 2011 Jul;35(7):937-48. doi: 10.1097/PAS.0b013e31821c3dae.

PMID:
21677534
22.

A global view of protein expression in human cells, tissues, and organs.

Pontén F, Gry M, Fagerberg L, Lundberg E, Asplund A, Berglund L, Oksvold P, Björling E, Hober S, Kampf C, Navani S, Nilsson P, Ottosson J, Persson A, Wernérus H, Wester K, Uhlén M.

Mol Syst Biol. 2009;5:337. doi: 10.1038/msb.2009.93. Epub 2009 Dec 22.

23.

A genecentric Human Protein Atlas for expression profiles based on antibodies.

Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, Persson A, Ottosson J, Wernérus H, Nilsson P, Lundberg E, Sivertsson A, Navani S, Wester K, Kampf C, Hober S, Pontén F, Uhlén M.

Mol Cell Proteomics. 2008 Oct;7(10):2019-27. doi: 10.1074/mcp.R800013-MCP200. Review.

24.

Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

Fradet Y, Egerdie B, Andersen M, Tammela TL, Nachabe M, Armstrong J, Morris T, Navani S.

Eur Urol. 2007 Jul;52(1):106-14. Epub 2007 Jan 16.

PMID:
17270340
25.

Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up.

Wirth M, Tyrrell C, Delaere K, Sánchez-Chapado M, Ramon J, Wallace DM, Hetherington J, Pina F, Heyns CF, Navani S, Armstrong J.

Prostate Cancer Prostatic Dis. 2007;10(1):87-93. Epub 2006 Nov 14.

PMID:
17102802
26.
27.

Addressing sexual violence in humanitarian emergencies.

Marsh M, Purdin S, Navani S.

Glob Public Health. 2006;1(2):133-46. doi: 10.1080/17441690600652787. Review.

PMID:
19153902
28.

Automated IHC stained slide service available to readers of IJPM.

Navani S.

Indian J Pathol Microbiol. 2004 Apr;47(2):308. No abstract available.

PMID:
16295511
29.

Tumors of the fimbriated end of the fallopian tube: a clinicopathologic analysis of 20 cases, including nine carcinomas.

Alvarado-Cabrero I, Navani SS, Young RH, Scully RE.

Int J Gynecol Pathol. 1997 Jul;16(3):189-96.

PMID:
9421082
30.

Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases.

Navani SS, Alvarado-Cabrero I, Young RH, Scully RE.

Gynecol Oncol. 1996 Dec;63(3):371-8.

PMID:
8946874
31.

Laryngeal squamous carcinoma associated with longstanding localised amyloidosis. A case report.

Navani SS, Simha M, Doctor VM, Haribhakti V, Mehta A.

Indian J Cancer. 1995 Mar;32(1):43-5. Review.

PMID:
7558112
32.

Abdominal cocoon--the cauliflower sign on barium small bowel series.

Navani S, Shah P, Pandya S, Doctor N.

Indian J Gastroenterol. 1995 Jan;14(1):19.

PMID:
7860113
33.

Intercostal pulmonary hernia after a bullet injury.

Ketkar M, Kamat V, Agrawal G, Navani S.

AJR Am J Roentgenol. 1994 Mar;162(3):728. No abstract available.

PMID:
8109529
34.

The case of a sticky stomach.

Navani S, Shah P, Abraham P.

Indian J Gastroenterol. 1993 Jul;12(3):107. No abstract available.

PMID:
8354528
35.

Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.

Sawant PD, Nanivadekar SA, Patel HD, Shroff CP, Oke VG, Jha RJ, Bowalekar SK, Navani SR, Raghu CN.

J Assoc Physicians India. 1990 Sep;38 Suppl 1:723-6.

PMID:
2092029
36.

Phase IV evaluation of piroxicam in acute and chronic painful inflammatory disorders: an Indian study.

Navani SR, Raghu CN, Jha RJ, Bowalekar SK, Oke VG.

Int J Tissue React. 1989;11(1):47-51.

PMID:
2681034
37.

Comparative evaluation of captopril and metoprolol as first choice anti-hypertensive in Indian patients.

Yajnik VH, Vatsraj DJ, Vora LS, Oke VG, Jha RJ, Patel K, Navani SR, Raghu CN.

Br J Clin Pract. 1988 Oct;42(10):407-11. No abstract available.

PMID:
3076468
38.

Spontaneous lung hernia.

Donato AT, Hipona FA, Navani S.

Chest. 1973 Aug;64(2):254-6. No abstract available.

PMID:
4725086
39.

Angionephrotomography and subtraction. Relative value in renal mass lesions.

Athanasoulis CA, Douglas EA, Navani S, Ferris EJ, Shapiro JH.

Am J Roentgenol Radium Ther Nucl Med. 1973 Jan;117(1):108-11. No abstract available.

PMID:
4568241
40.

Evanescent enlargement of salivary glands following tri-iodinated contrast media.

Navani S, Taylor CE, Kaufman SA, Parlee RH.

Br J Radiol. 1972 Jan;45(529):19-20. No abstract available.

PMID:
5008326
41.

Renal homotransplantation: spectrum of angiographic findings of the kidney.

Navani S, Athanasoulis CA, Monaco AP, Cavallo T, Lewis EJ, Hipona FA.

Am J Roentgenol Radium Ther Nucl Med. 1971 Nov;113(3):433-42. No abstract available.

PMID:
4942605
42.

Multiple pleural nodules.

Sciammas FD, Shetty S, Navani S.

Chest. 1971 Jun;59(6):673-4. No abstract available.

PMID:
5087939
43.

A digital computer program for the statistical analysis of heat resistance data applied to Bacillus stearothermophilus spores.

Navani SK, Scholefield J, Kibby MR.

J Appl Bacteriol. 1970 Dec;33(4):609-20. No abstract available.

PMID:
5516592
44.

Spontaneous regression of pulmonary metastases from transitional cell carcinoma of the bladder.

Lome LG, Navani S, Aral IM.

Cancer. 1970 Aug;26(2):415-8. No abstract available.

PMID:
5451218
45.

A giant calculus in an ileal conduit.

Navani S, Diznoff B, Collins W, Marchant D.

J Urol. 1970 Aug;104(2):269-70. No abstract available.

PMID:
5448900
46.

Foley calculus formation.

Lome LG, Navani S.

Br J Radiol. 1970 Jul;43(511):487-8. No abstract available.

PMID:
5429090
47.

Determination of sex by costal cartilage calcification.

Navani S, Shah JR, Levy PS.

Am J Roentgenol Radium Ther Nucl Med. 1970 Apr;108(4):771-4. No abstract available.

PMID:
5437281
48.

A primary vaginal stone.

Navani S, Tessier PA.

Br J Radiol. 1970 Mar;43(507):222-3. No abstract available.

PMID:
5436361
49.

The cerebral venogram: a statistical analysis of the sequence of venous filling in cerebral angiograms.

Bub B, Ferris EJ, Levy PS, Navani S.

Radiology. 1968 Dec;91(6):1112-8. No abstract available.

PMID:
5699612
50.

Ureteral diverticulosis.

Navani S, Hipona FA, Shapiro JH.

Am J Roentgenol Radium Ther Nucl Med. 1968 Oct;104(2):364-5. No abstract available.

PMID:
4971873

Supplemental Content

Loading ...
Support Center